Relay Therapeutics to Participate in Two Upcoming Investor Conferences
25 5월 2023 - 5:05AM
Relay Therapeutics, Inc. (Nasdaq: RLAY) today announced that
management will participate in two upcoming fireside chats:
- TD Cowen 4th Annual Oncology Innovation Summit, taking place
virtually on Tuesday, May 30, 2023 at 1:00 p.m. ET
- Goldman Sachs 44th Annual Global Healthcare Conference on
Tuesday, June 13, 2023 at 10:00 a.m. PT
The fireside chats will be webcast live and may be accessed
through Relay Therapeutics’ website under Events in the News &
Events section through the following link:
https://ir.relaytx.com/news-events/events-presentations. An
archived replay of the webcasts will be available for up to 30 days
following each event.
About Relay Therapeutics
Relay Therapeutics is a clinical-stage precision medicine
company transforming the drug discovery process by combining
leading-edge computational and experimental technologies with the
goal of bringing life-changing therapies to patients. As the first
of a new breed of biotech created at the intersection of
complementary techniques and technologies, Relay Therapeutics aims
to push the boundaries of what’s possible in drug discovery. Its
Dynamo™ platform integrates an array of leading-edge computational
and experimental approaches designed to drug protein targets that
have previously been intractable or inadequately addressed. Relay
Therapeutics’ initial focus is on enhancing small molecule
therapeutic discovery in targeted oncology and genetic disease
indications. For more information, please visit www.relaytx.com or
follow us on Twitter.
Contact:Megan Goulart617-545-5526
mgoulart@relaytx.com
Media:Dan
Budwick1AB973-271-6085dan@1abmedia.com
Relay Therapeutics (NASDAQ:RLAY)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Relay Therapeutics (NASDAQ:RLAY)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024